Psychomotor performance and monoamine function in bipolar and unipolar affective disorders

Biological Psychiatry

Volumn 45, Issue 8, 1999, Pages 979-988

  Swann, Alan C ^a   Katz, Martin M ^b   Bowden, Charles L ^c   Berman, Nancy G ^d   Stokes, Peter E ^e  

^a UNIVERSITY OF TEXAS   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Affective disorder; Age; Bipolar disorder; Catecholamines; Depression; Dexterity; Mania; Mixed state; Psychomotor; Reaction time; Trail making test

Indexed keywords

CATECHOLAMINE;

ADULT; AGED; ARTICLE; CATECHOLAMINE BRAIN LEVEL; CATECHOLAMINE METABOLISM; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; DEPRESSION; EYE TRACKING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MONOAMINE METABOLISM; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RESPONSE TIME;

ADULT; AGED; BIPOLAR DISORDER; CATECHOLAMINES; DEPRESSIVE DISORDER; EYE MOVEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR DISORDERS; REACTION TIME; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0033560689     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00172-3     Document Type: Article

References (43)

1. Adler L.E., Gerhardt G.A., Franks R., Baker N., Nagamoto H., Drebing C., et al. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res. 31:1990;297-309.
2. Bunney W.E., Goodwin F.K., Murphy D.L. The "switch process" in manic-depressive illness III. Theoretical implications . Arch Gen Psychiatry. 27:1972;312-317.
3. Carr V., Edwards J., Prior M. Urinary MHPG, platelet 3H-imipramine binding and symptomatology in depression An exploratory study of clinical heterogeneity . Biol Psychiatry. 23:1988;560-574.
4. Clark C.R., Geffen G.M., Geffen L.B. Catecholamines and attention I Animal and clinical studies . Neurosci Biobehav Rev. 11:1987;341-352.
5. Filzer J.G., Muller W.E., Beckmann H. Should plasma or urinary MHPG be measured in psychiatric research? A critical comment. Br J Psychiatry. 148:1986;95-97.
6. Hart R.P., Kwentus J.A. Psychomotor slowing and subcortical-type dysfunction in depression. J Neurol Neurosurg Psychiatry. 50:1987;1263-1266.
7. Katz M.M., Robins E., Croughan J., Secunda S., Swann A. Behavioral measurement and drug response characteristics of unipolar and bipolar depression. Psychol Med. 12:1982;25-36.
8. Katz M.M., Secunda S.K., Koslow S.H., Maas J.W., Berman N., Casper R., et al. A multivantaged approach to measurement of behavioral and affect states for clinical and psychobiological research. Psychol Rep. 55:1984;619-671.
9. King H.E. Reaction time and speed of voluntary movement by normal and psychotic subjects. J Psychol. 59:1965;219-227.
10. King H.E. Trail-making performance related to Psychotic state, age, intelligence, education, and fine psychomotor ability . Percept Mot Skills. 25:1965;649-658.
11. King H.E. Psychomotility A dimension of behavior disorder . Proc Am Psychopathol Assoc. 58:1969;99-131.
12. Klein E., Lavie P., Meiraz R., Sadeh A., Lenox R.H. Increased motor activity and recurrent manic episodes Predictors of rapid relapse in remitted bipolar disorder patients after lithium discontinuation . Biol Psychiatry. 31:1992;279-284.
13. Koslow S.H., Maas J.W., Bowden C., Davis J.M., Hanin I., Javaid J. Cerebrospinal fluid and urinary biogenic amines and metabolites in depression, mania, and healthy controls. Arch Gen Psychiatry. 40:1983;999-1010.
14. Koslow S.H., Maas J.W., Bowden C.L., Davis J.M., Hanin I., Javaid J. Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamines and metabolites. Arch Gen Psychiatry. 43:1986;1012-1013.
15. Lenter M. Elementary Applied Statistics. 1972;247-249 Bogden & Quigley, Tarrytown-on-Hudson, NY.
16. Lezak M. Neuropsychological Assessment. 1983;340 Oxford University Press, New York.
17. Lorr M., Hamlin R.M. A multimethod factor analysis of behavioral and objective measures of psychopathology. J Consult Clin Psychol. 36:1971;136-141.
18. Maas J.W., Koslow S.H., Davis J.M., Katz M.M., Mendels J., Robins E., et al. Biological component of the NIMH Clinical Research Branch Collaborative Program on the Psychobiology of Depression I. Background and theoretical implications . Psychol Med. 10:1980;759-776.
19. Maas J.W., Koslow S.H., Katz M.M., Bowden C.L., Gibbons R.L., Stokes P.E., et al. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. Am J Psychiatry. 141:1984;1159-1171.
20. Maas J.W., Koslow S.H., Davis J.M., Katz M.M., Frazer A., Bowden C.L., et al. Catecholamine metabolism and disposition in healthy and depressed subjects. Arch Gen Psychiatry. 44:1987;337-344.
21. Price L.H., Charney D.S., Heninger G.R. Three cases of manic symptoms following yohimbine administration. Am J Psychiatry. 141:1984;1267-1268.
22. Redmond D.E. Jr, Katz M.M., Maas J.W., Swann A.C., Casper R., Davis J.M. CSF biogenic amine metabolite relationships with behavioral measurements in depressed, manic, and healthy control subjects. Arch Gen Psychiatry. 43:1986;938-947.
23. Roy A., Pickar D., Linnoila M., Doran A., Ninan P.T., Paul S.M. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Psychiatry Res. 15:1985;281-292.
24. Schwartz F., Carr A.C., Munich R.L., Glauber S., Lesser B., Murray J. Reaction time impairment in schizophrenia and affective illness The role of attention . Biol Psychiatry. 25:1989;540-548.
25. Secunda S., Koslow S.H., Redmond D.E. Jr, Garver D.L., Ramsey T.A., Croughan J., et al. Biological component of the NIMH Clinical Research Branch Collaborative Program on the Psychobiology of Depression II. Methodology and data analysis . Psychol Med. 10:1980;777-793.
26. Secunda S., Katz M.M., Swann A.C., Koslow S.H., Maas J.W., Chang S., Croughan J. Mania Diagnosis, state measurement, and prediction of treatment response . J Affect Disord. 8:1985;113-121.
27. Silberman E.K., Rues V.I., Jimerson D.C., Lynott A.M., Post R.M. Heterogeneity of amphetamine response in depressed patients. Am J Psychiatry. 138:1981;1302-1307.
28. Sobin C., Sackeim H.A. Psychomotor symptoms of depression. Am J Psychiatry. 154:1997;4-17.
29. Sourkes T.L. Pathways of stress in the CNS. Prog Neuropsychopharmacol Biol Psychiatry. 7:1983;389-411.
30. Spitzer R.L., Endicott J. Schedule for Affective Disorders and Schizophrenia. 3rd ed. 1978;New York State Psychiatric Institute Biometrics Institute, New York.
31. Spitzer R.L., Endicott J., Robins E. Research Diagnostic Criteria for a Selected Group of Functional Disorders. 3rd ed. 1978;New York State Psychiatric Institute Biometrics Institute, New York.
32. Swann A.C., Koslow S.H., Katz M.M., Maas J.W., Javaid J., Secunda S.K., et al. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Arch Gen Psychiatry. 44:1987;345-354.
33. Swann A.C., Secunda S.K., Stokes P.E., Croughan J., Davis J.M., Koslow S.H., et al. Stress, depression, and mania Relationship between perceived role of stressful events and clinical and biochemical characteristics . Acta Psychiatr Scand. 81:1990;389-397.
34. Swann A.C., Secunda S.K., Koslow S.H., Katz M.M., Bowden C.L., Maas J.W., et al. Mania Sympathoadrenal function and clinical state . Psychiatry Res. 37:1991;195-205.
35. Swann A.C., Stokes P.E., Casper R., Secunda S.K., Bowden C.L., Berman N., et al. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand. 85:1992;270-274.
36. Swann A.C., Secunda S.K., Katz M.M., Croughan J., Bowden C.L., Koslow S.H., et al. Specificity of mixed affective states Clinical comparison of mixed mania and agitated depression . J Affect Disord. 28:1993;81-89.
37. Swann A.C., Stokes P.E., Secunda S., Maas J.W., Bowden C.L., Berman N., et al. Depressive mania vs agitated depression Biogenic amine and hypothalamic-pituitary-adrenocortical function . Biol Psychiatry. 35:1994;803-813.
38. Weaver L.A.J., Brooks G.W. Differential performance on psychomotor tests by hospitalized acute and chronic mental patients. Psychiatr Q. 41:1967;286-295.
39. Wehr T.A., Muscettola G., Goodwin F.K. Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm Early timing (phase advance) in manic-depressives compared with normal subjects . Arch Gen Psychiatry. 37:1980;257-263.
40. Whybrow P., Mendels J. Toward a biology of depression Some suggestions from neurophysiology . Am J Psychiatry. 125:1969;45-54.
41. Winer B.J. Statistical Principles in Experimental Design. 2nd ed. 1971;McGraw-Hill, New York.
42. Wolff E.A.I., Putnam F.W., Post R.M. Motor activity and affective illness The relationship of amplitude and temporal distribution to changes in affective state . Arch Gen Psychiatry. 42:1985;288-294.
43. Zahn T.P., Nurnberger J.J., Berrettini W.H. Electrodermal activity in young adults at genetic risk for affective disorder. Arch Gen Psychiatry. 46:1989;1120-1124.